Drug Type Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms synthetic human papillomavirus 16 E6 peptide(NCI) |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anus Neoplasms | Phase 1 | United States | 01 Nov 1995 | |
| Esophageal Carcinoma | Phase 1 | United States | 01 Nov 1995 | |
| Locally Advanced Cervical Carcinoma | Phase 1 | United States | 01 Nov 1995 | |
| Metastatic Cervical Carcinoma | Phase 1 | United States | 01 Nov 1995 | |
| Penile Neoplasms | Phase 1 | United States | 01 Nov 1995 | |
| Recurrent Carcinoma | Phase 1 | United States | 01 Nov 1995 | |
| Vulvar Neoplasms | Phase 1 | United States | 01 Nov 1995 |





